MedPath

Prospective immune biomarker identification trial for renal cell carcinoma treatment.

Not Applicable
Recruiting
Conditions
Renal cell carcinoma
Registration Number
JPRN-UMIN000047119
Lead Sponsor
Keio University, school of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Minors

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Identification of immune factors which correlates with outcomes.
Secondary Outcome Measures
NameTimeMethod
Identification of immune factors which correlates with clinical factors.
© Copyright 2025. All Rights Reserved by MedPath